Psoriasis Redefined Webinar Series
A series of two CPD certified modules, presented by recognised experts in clinical psoriasis to support you should you decide to use BIMZELX® ▼ (bimekizumab) for treating your eligible adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.
The BIMZELX® Difference
The BIMZELX® Experience
Report adverse events
Help us to grow our resource the way you want it to grow.